These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 34838005)
1. NEDD4L-induced ubiquitination mediating UBE2T degradation inhibits progression of lung adenocarcinoma via PI3K-AKT signaling. Chen Y; Hong H; Wang Q; Li J; Zhang W; Chen T; Li P Cancer Cell Int; 2021 Nov; 21(1):631. PubMed ID: 34838005 [TBL] [Abstract][Full Text] [Related]
2. UBE2T mediates SORBS3 ubiquitination to enhance IL-6/STAT3 signaling and promote lung adenocarcinoma progression. Pu J; Wang B; Zhang D; Wang K; Yang Z; Zhu P; Song Q J Biochem Mol Toxicol; 2024 Jun; 38(6):e23743. PubMed ID: 38816989 [TBL] [Abstract][Full Text] [Related]
3. Down-regulated NEDD4L facilitates tumor progression through activating Notch signaling in lung adenocarcinoma. Lin L; Wu X; Jiang Y; Deng C; Luo X; Han J; Hu J; Cao X PeerJ; 2022; 10():e13402. PubMed ID: 35646490 [TBL] [Abstract][Full Text] [Related]
4. UBE2T promotes stage I lung adenocarcinoma progression through PBX1 ubiquitination and PBX1/RORA regulation. Deng Y; Chen X; Chen X; Huang C; Zhang Z; Xu Z; Wang X; Wu J; Li L; Song J; Zhou R BMC Cancer; 2024 Sep; 24(1):1158. PubMed ID: 39289660 [TBL] [Abstract][Full Text] [Related]
5. Knockdown of ubiquitin-conjugating enzyme E2T (UBE2T) suppresses lung adenocarcinoma progression via targeting fibulin-5 (FBLN5). Li Y; Yang X; Lu D Bioengineered; 2022 May; 13(5):11867-11880. PubMed ID: 35543375 [TBL] [Abstract][Full Text] [Related]
6. FOXA1/UBE2T Inhibits CD8 Pu J; Zhang D; Wang B; Zhu P; Yang W; Wang K; Yang Z; Song Q Front Biosci (Landmark Ed); 2024 Apr; 29(4):134. PubMed ID: 38682180 [TBL] [Abstract][Full Text] [Related]
7. NEDD4L Protein Catalyzes Ubiquitination of PIK3CA Protein and Regulates PI3K-AKT Signaling. Wang Z; Dang T; Liu T; Chen S; Li L; Huang S; Fang M J Biol Chem; 2016 Aug; 291(33):17467-77. PubMed ID: 27339899 [TBL] [Abstract][Full Text] [Related]
8. JAC4 Inhibits EGFR-Driven Lung Adenocarcinoma Growth and Metastasis through CTBP1-Mediated JWA/AMPK/NEDD4L/EGFR Axis. Ding K; Jiang X; Wang Z; Zou L; Cui J; Li X; Shu C; Li A; Zhou J Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240137 [TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53. Wu M; Li X; Huang W; Chen Y; Wang B; Liu X Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946 [TBL] [Abstract][Full Text] [Related]
10. UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma. Zhu J; Ao H; Liu M; Cao K; Ma J J Transl Med; 2021 Aug; 19(1):374. PubMed ID: 34461934 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of NEDD4L by EGFR signaling promotes the development of lung adenocarcinoma. Li G; Song Z; Wu C; Li X; Zhao L; Tong B; Guo Z; Sun M; Zhao J; Zhang H; Jia L; Li S; Wang L J Transl Med; 2022 Jan; 20(1):47. PubMed ID: 35090513 [TBL] [Abstract][Full Text] [Related]
12. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma. Hao P; Kang B; Li Y; Hao W; Ma F Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226 [TBL] [Abstract][Full Text] [Related]
13. UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism. Zhu Z; Cao C; Zhang D; Zhang Z; Liu L; Wu D; Sun J Cell Death Dis; 2022 Feb; 13(2):154. PubMed ID: 35169125 [TBL] [Abstract][Full Text] [Related]
14. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation. Sun J; Zhu Z; Li W; Shen M; Cao C; Sun Q; Guo Z; Liu L; Wu D J Exp Clin Cancer Res; 2020 Oct; 39(1):222. PubMed ID: 33087136 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of UBE2T and Its Correlation with Immune Infiltrates in Lung Adenocarcinoma. Xu F; Xiong N; Yuan Y; Liu J J Oncol; 2022; 2022():5244820. PubMed ID: 36245987 [TBL] [Abstract][Full Text] [Related]
16. UBE2T promotes glioblastoma malignancy through ubiquitination-mediated degradation of RPL6. Tao X; Wu X; Zhou P; Yu X; Zhao C; Peng X; Zhang K; Shen L; Peng J; Yang L Cancer Sci; 2023 Feb; 114(2):521-532. PubMed ID: 36156329 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-1305 Inhibits the Stemness of LCSCs and Tumorigenesis by Repressing the UBE2T-Dependent Akt-Signaling Pathway. Wei X; You X; Zhang J; Zhou C Mol Ther Nucleic Acids; 2019 Jun; 16():721-732. PubMed ID: 31128423 [TBL] [Abstract][Full Text] [Related]
18. Knockdown of UBE2T Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion by Suppressing the PI3K/Akt Signaling Pathway. Wang Y; Leng H; Chen H; Wang L; Jiang N; Huo X; Yu B Oncol Res; 2016; 24(5):361-369. PubMed ID: 27712593 [TBL] [Abstract][Full Text] [Related]
20. Targeting STT3A produces an anti-tumor effect in lung adenocarcinoma by blocking the MAPK and PI3K/AKT signaling pathway. Cheng J; Xia L; Hao X; Gan F; Bai Y; Zhang C; Mao Y; Zhu Y; Pu Q; Park DW; Tavolari S; Mei J; Chen Y; Deng S; Liu L Transl Lung Cancer Res; 2022 Jun; 11(6):1089-1107. PubMed ID: 35832442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]